Font Size: a A A
Keyword [Acute myeloid leukemia (AML)]
Result: 41 - 60 | Page: 3 of 4
41. Intravoxel Incoherent Motion Diffusion-weighted Imaging In Clinical Application Of Acute Myeloid Leukemia With Bone Marrow:A Pilot Study
42. The Expression Of Serum UPA Is Related To The Prognosis Of Acute Myeloid Leukemia And A Preliminary Investigation On The Related Signaling Pathway
43. Analysis Of Efficacy And Adverse Reactions Of Cytarabine For Consolidation In 85 Patients With Acute Myeloid Leukemia (Not M3) In Qilu Hospital Of Shandong University
44. Preliminary Explore The Clinical Significance Of Chemotherapy Combined With Autologous Cytokine-Induced Killer Cells Sequential Therapy In Elderly Patients With Acute Myeloid Leukemia
45. Comparison Of Clinical Efficacy Between Low-dose Ma Regimen And Cag Regimen In The Elderly Patients With Acute Myeloid Leukemia(AML)
46. Analysis Of DNMT3A Gene Mutation In 342 Patients With Acute Myeloid Leukemia And Its Clinical Significance
47. Expression Difference And Prognostic Significance Of CD7 In AML Patients With Wild Type And Mutant Of CEBPA
48. Activity And Mechanism Of Action Of The Novel Bcl-2 Selective Inhibitor ABT-199 In Acute Myeloid Leukemia
49. MiR-34c-5p Promotes Eradication Of Acute Myeloid Leukemic Stem Cells By Inducing Senescence Via Selectively Targeting RAB27B To Inhibit Exosomes Shedding
50. The Distribution And Mechanism Of Regulatory B Cells In Acute Myeloid Leukemia
51. The Roles Of Ars2 In Acute Myeloid Leukemia By Modulating The MiR-6734-3p/p27 Axis
52. The Landscape Of Gene Mutations In Acute Myeloid Leukemia(AML)patients With Intermediate-risk-cytogenetic-group
53. Influence Of AML Cells On Gene Expression And Function Of Bone Marrow Mesenchymal Stromal Cells
54. Clinical And Mechanistic Study Of Low-dose Decitabine As Part Of Modified Bucy-conditioning In Improving Prognosis Of High-risk AML Patients
55. Preliminary Study On Biological And Genetical Characteristics Of Bone Marrow Mesenchymal Stem Cells In Myeloid Neoplasms
56. Clinical Study On Efficacy And Safety Of Decitabine Sequential Or Simultaneous With "3+7" Regimenin In The Treatment Of Patients With Newly Diagnosed Acute Myeloid Leukemia
57. A Preliminary Study On The Expression Profile Of Exosomal MicroRNA In Acute Myeloid Leukemia Patient
58. WT1 Gene Expression And Its Prognostic Value In Acute Myeloid Leukemia Patients
59. The Relationship Between The Changes Of Th17 Cells In The Peripheral Blood And Disease Stage And Risk Stratification In Patients With Acute Myeloid Leukemia
60. Clinical Observation On The Efficacy Of Recombinant Human Interleukin-2 In The Treatment Of Low And Medium Risk Non-M3 Aute Myeloid Leukemia
  <<First  <Prev  Next>  Last>>  Jump to